IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies
Christian Leborgne, Elena Barbon, Jeffrey M. Alexander, Hayley A. Hanby, Sandrine Delignat, Daniel M. Cohen, Fanny Collaud, Saghana Muraleetharan, Daniel Lupo, Joseph Silverberg, Karen Huang, Laetitia van Wittenberghe, Béatrice Marolleau, Adeline Miranda, Anna Fabiano, Victoria Daventure, Heena Beck, Xavier M. Anguela, Giuseppe Ronzitti, Sean M. Armour, Sébastien Lacroix‐Desmazes, Federico Mingozzi
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1038/s41591-020-0911-7
- Published
- Jun 1, 2020
- Venue
- Nature Medicine
- DOI
- 10.1038/s41591-020-0911-7
- PubMed
- 32483358
- Categories
- Virus-based gene therapy research
- License
- other-oa
- Provenance
- openalex